Gusperimus

Gusperimus · Nippon Kayaku Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Gusperimus, covering 2015-05-29 to 2017-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis [Phase 2]